Pfizer Announces its Vaccine May Soon be Administered to Children

The Chairman and CEO of Pfizer announced on Tuesday, May 4, that it expects the FDA to expand Emergency Use Authorization, allowing children ages 12-15 to receive its vaccine. Previously, the cut-off age was 16, but Pfizer has stated that the results of testing of its vaccine will allow the younger-aged children to safely receive the vaccine. Pfizer expects FDA approval as early as next week.